Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00482352 · ClinicalTrials.gov registry record
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 11,196
- Enrollment target
NCT00482352 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 11,196 participants.
The verdict
NCT00482352 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 11,196 participants
- Enrollment target
Study Summary
This clinical trial is studying risk-group classification of patients with newly diagnosed acute lymphoblastic leukemia. Developing a risk-group classification guide may help doctors assign patients with newly diagnosed acute lymphoblastic leukemia to treatment clinical trials.
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,196 participants |
| Start Date | 2003-12 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00482352
The ClinicalTrials.gov registry entry for NCT00482352 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11,196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT00482352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00482352 about?
NCT00482352 is a clinical study titled "Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia". This clinical trial is studying risk-group classification of patients with newly diagnosed acute lymphoblastic leukemia. Developing a risk-group classification guide may help doctors assign patients with newly diagnosed acute lymphoblastic leukemia to treatment clinical trials.
What is the current status of trial NCT00482352?
This trial is currently completed. The enrollment target is 11,196 participants. The study started on 2003-12. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT00482352?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00482352?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.